CpG motifs for optimization of DNA vaccines
- PMID: 11713816
CpG motifs for optimization of DNA vaccines
Abstract
The immunogenicity of DNA vaccines is due in part to the presence of stimulatory CpG motifs, which may actually be essential to their function. CpG motifs are unmethylated cytosine-guanine dinucleotides within a certain flanking base context and such sequences are commonly found in bacterial but not mammalian DNA. It appears that through evolutionary adaptation, the vertebrate immune system developed the ability to recognize these sequences as a "danger signal" and respond by rapid activation of the innate immune system. This innate activation synergizes with signals mediated through antigen receptors, and thus also augments antigen-specific responses. Other sequences, known as "neutralizing" motifs, which can counteract stimulatory CpG motifs, are also found in DNA vaccines. The immunogenicity of a DNA vaccine may depend on the balance between stimulatory and neutralizing motifs, and if so, their efficacy might be improved through the removal of neutralizing motifs and addition of species-specific stimulatory CpG motifs.
Similar articles
-
Enhancing vaccines with immune stimulatory CpG DNA.Curr Opin Mol Ther. 2001 Feb;3(1):15-24. Curr Opin Mol Ther. 2001. PMID: 11249727 Review.
-
The role of CpG dinucleotides in DNA vaccines.Trends Microbiol. 1998 Jan;6(1):23-7. doi: 10.1016/S0966-842X(97)01145-1. Trends Microbiol. 1998. PMID: 9481820 Review.
-
Adjuvant activity of CpG oligodeoxynucleotides.Int Rev Immunol. 2006 May-Aug;25(3-4):135-54. doi: 10.1080/08830180600743057. Int Rev Immunol. 2006. PMID: 16818369 Review.
-
Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant.Vaccine. 2005 Jan 4;23(7):873-83. doi: 10.1016/j.vaccine.2004.08.019. Vaccine. 2005. PMID: 15603887
-
Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.Jpn J Infect Dis. 2002 Apr;55(2):37-44. Jpn J Infect Dis. 2002. PMID: 12082305 Review.
Cited by
-
Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines.Med Microbiol Immunol. 2015 Aug;204(4):481-91. doi: 10.1007/s00430-014-0359-9. Epub 2014 Sep 30. Med Microbiol Immunol. 2015. PMID: 25265876
-
Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120.Genet Vaccines Ther. 2007 Jan 29;5:3. doi: 10.1186/1479-0556-5-3. Genet Vaccines Ther. 2007. PMID: 17261176 Free PMC article.
-
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.Clin Exp Med. 2024 Dec 25;25(1):24. doi: 10.1007/s10238-024-01541-7. Clin Exp Med. 2024. PMID: 39720956 Free PMC article. Review.